Earlier this month Colorado became the 30th state to mandate that women with dense breast tissue get told about it when they receive results from their mammograms. This week an area newspaper spotlighted a radiologist who helped push the legislation through.

Michelle Bautista, from Panama City, Florida, is challenging her community to raise enough funds to provide 100 women mammograms. In addition to raising funds, she is also offering free mammograms at her own clinic for the next month.  

Screening mammography providers “on wheels” planning to serve medically underserved Latino communities would do well to first communicate with each community on perceptions of such services and, where needed, to offer education prior to rolling in.

Following screening mammography that turns up nothing, women with dense breast tissue are much more likely to pursue additional imaging with automated breast ultrasound (ABUS) when two things happen: their radiologists inform them of their tissue density and encourage them to consider the secondary exam because of it.

Image quality in mammography, thanks to concerns about radiation dose, faces a Goldilocks problem—where radiologists want to get the best image possible, while also minimizing risk to the patient. 

A new breast cancer screening technology is adding itself to the list of traditional imaging technologies in New York state hospitals.  

Thirteen of 75 patients who had abnormal incidental findings in the breast after undergoing chest CT, or 17.3 percent, ended up indeed having breast cancer in a recent study, prompting the authors to recommend follow-up breast-specific imaging in all such cases.

Can a genomics blood test catch signature bits of DNA that break off of breast-cancer cells and float through the bloodstream? If so, can the test reliably confirm mammography findings—or possibly alert clinicians to the presence of a tumor even more quickly than imaging can?